Ekso Bionics Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Accumulated Other Comprehensive Income (Loss) (Tables)

6 Months Ended

Jun. 30, 2023

	*Six Months Ended June 30,*
	*2023*			*2022*
Balance at beginning of period	$	563		$	(17	)
Net unrealized (loss) gain on foreign currency translation		(204	)		851
Balance at end of period	$	359		$	834